Revenue
$123.7M
▲ 63.5% YoY
Net Income
-$38.6M
▲ 46.9% YoY
EPS
-
Cash
$129.9M
▼ 42.1% YoY
FY 2025 · As of 2025-12-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
Dunn Edmund Principal Accounting Officer | Sell | Mar 4, 2026 | 139 | $17.96 | $2K | Form 4 ↗ |
Warmuth Markus President & CEO | Sell | Mar 2, 2026 | 5.5K | $17.92 | $98K | Form 4 ↗ |
Dunn Edmund Principal Accounting Officer | Vest | Mar 2, 2026 | 536 | $13.41 | $7K | Form 4 ↗ |
Dunn Edmund Principal Accounting Officer | Sell | Mar 2, 2026 | 536 | $17.50 | $9K | Form 4 ↗ |
Dunn Edmund Principal Accounting Officer | Vest | Feb 27, 2026 | 25.2K | $13.41 | $337K | Form 4 ↗ |
Dunn Edmund Principal Accounting Officer | Sell | Feb 27, 2026 | 25.2K | $18.10 | $456K | Form 4 ↗ |
Janku Filip Chief Medical Officer | Sell | Feb 23, 2026 | 9.2K | $19.50 | $179K | Form 4 ↗ |
Warmuth Markus President & CEO | Sell | Jan 7, 2026 | 3.7K | $23.24 | $86K | Form 4 ↗ |
Warmuth Markus President & CEO | Sell | Jan 7, 2026 | 1.4K | $23.88 | $35K | Form 4 ↗ |
Warmuth Markus President & CEO | Sell | Jan 7, 2026 | 309 | $24.57 | $8K | Form 4 ↗ |
Nickson Philip Chief Business & Legal Officer | Sell | Jan 5, 2026 | 3.2K | $15.17 | $48K | Form 4 ↗ |
Champoux Jennifer Chief Operating Officer | Sell | Jan 5, 2026 | 2.6K | $15.17 | $40K | Form 4 ↗ |
Dunn Edmund Principal Accounting Officer | Sell | Jan 5, 2026 | 1.0K | $15.17 | $16K | Form 4 ↗ |
Warmuth Markus President & CEO | Sell | Jan 5, 2026 | 10.1K | $15.17 | $154K | Form 4 ↗ |
Janku Filip Chief Medical Officer | Sell | Jan 5, 2026 | 3.2K | $15.17 | $48K | Form 4 ↗ |
Townson Sharon Chief Scientific Officer | Sell | Jan 5, 2026 | 3.2K | $15.17 | $48K | Form 4 ↗ |
Nickson Philip Chief Business & Legal Officer | Grant | Jan 2, 2026 | 28.0K | - | - | Form 4 ↗ |
Champoux Jennifer Chief Operating Officer | Grant | Jan 2, 2026 | 35.0K | - | - | Form 4 ↗ |
Warmuth Markus President & CEO | Grant | Jan 2, 2026 | 90.0K | - | - | Form 4 ↗ |
Janku Filip Chief Medical Officer | Grant | Jan 2, 2026 | 31.0K | - | - | Form 4 ↗ |
Townson Sharon Chief Scientific Officer | Grant | Jan 2, 2026 | 35.0K | - | - | Form 4 ↗ |